Hepatitis C virus genetic variability in patients undergoing antiviral therapy
- 1 August 2007
- journal article
- review article
- Published by Elsevier in Virus Research
- Vol. 127 (2) , 185-194
- https://doi.org/10.1016/j.virusres.2007.02.023
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanismsProceedings of the National Academy of Sciences, 2006
- Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectivelyProceedings of the National Academy of Sciences, 2006
- Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infectionProceedings of the National Academy of Sciences, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- The error thresholdVirus Research, 2005
- Monitoring Sequence Space as a Test for the Target of Selection in VirusesJournal of Molecular Biology, 2005
- Antiviral strategy on the horizonVirus Research, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Ribavirin Causes Error Catastrophe during Hantaan Virus ReplicationJournal of Virology, 2003
- Selective transmission of hepatitis C virus in vivo and in vitroArchiv für die gesamte Virusforschung, 1995